1 / 9

EU funding opportunities

EU funding opportunities. E-Rare FP-7. E-Rare. Only for participating countries (not yet known) The call will be out 11/2010, application by 2/2011 16 projects will be funded, 1 Mio. Euro per year. FP7: ORIENTATION PAPER Proposed priorities for health research 2011.

ojal
Download Presentation

EU funding opportunities

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. EU funding opportunities • E-Rare • FP-7

  2. E-Rare • Only for participating countries (not yet known) • The call will be out 11/2010, application by 2/2011 • 16 projects will be funded, 1 Mio. Euro per year

  3. FP7: ORIENTATION PAPERProposed priorities for health research 2011 • Key research challenges: • Epigenomics • Supporting innovative clinical trials to verify safety and efficacy

  4. FP7

  5. FP7

  6. ORIENTATION PAPERProposed priorities for health research 2011 • 1.1 HIGH-THROUGHPUT RESEARCH • …including fundamental genomics that will significantly enhance data generation and improve data and specimen (bio-banks) standardisation, acquisition and analysis. The focus is on new technologies for: sequencing; gene expression, genotyping and phenotyping; structural and functional genomics; bioinformatics and systems biology; other 'omics'. • Impact on medicine and SME (6 Mio Euro)

  7. FP7

  8. ORIENTATION PAPERProposed priorities for health research 2011 • 1.4-5: New therapeutic approaches in chronic inflammatory and autoimmune diseases. • Projects should aim to develop innovative strategies to therapy based on various approaches, such as small molecules, antibodies, peptides or cells, where understanding of mechanism of action has already been established. • Cooperation with Brasil, 3 Mio. Euro

  9. FP7 10/2011

More Related